世界のピラルビシン市場予測（～2028年）：10mg剤形、20Mg剤形

• 英文タイトル：Global Pirarubicin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8937 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

ピラルビシン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のピラルビシンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 ピラルビシン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・10mg剤形、20Mg剤形 用途別セグメントは次のように区分されます。 ・乳がん、頭頸部がん、膀胱がん、尿管がん、腎盂がん、卵巣がん、子宮頸がん、悪性リンパ腫、急性白血病、その他 世界のピラルビシン市場の主要な市場プレーヤーは以下のとおりです。 ・MicroBiopharm、Lilly、Nanjing Zhengda Tianqing Pharmaceutical、Harbin Yuheng Pharmaceutical、Shandong New Era Pharmaceutical、Zhejiang Haizheng Pharmaceutical、Shenzhen Wanle Pharmaceutical 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、ピラルビシン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なピラルビシンメーカーの企業概要、2019年～2022年までのピラルビシンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なピラルビシンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別ピラルビシンの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのピラルビシンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのピラルビシン市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびピラルビシンの産業チェーンを掲載しています。 ・第13、14、15章では、ピラルビシンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：MicroBiopharm、Lilly、Nanjing Zhengda Tianqing Pharmaceutical、Harbin Yuheng Pharmaceutical、Shandong New Era Pharmaceutical、Zhejiang Haizheng Pharmaceutical、Shenzhen Wanle Pharmaceutical ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：10mg剤形、20Mg剤形 ・用途別分析2017年-2028年：乳がん、頭頸部がん、膀胱がん、尿管がん、腎盂がん、卵巣がん、子宮頸がん、悪性リンパ腫、急性白血病、その他 ・ピラルビシンの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・ピラルビシンのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・ピラルビシンのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ピラルビシンの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・ピラルビシンの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Pirarubicin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pirarubicin market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Breast Cancer accounting for % of the Pirarubicin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 10 Mg Dosage Forms segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Pirarubicin include MicroBiopharm, Lilly, Nanjing Zhengda Tianqing Pharmaceutical, Harbin Yuheng Pharmaceutical, and Shandong New Era Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pirarubicin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
10 Mg Dosage Forms
20 Mg Dosage Forms
Market segment by Application can be divided into
Breast Cancer
Head And Neck Cancer
Bladder Cancer
Ureteral Carcinoma
Carcinoma Of The Renal Pelvis
Ovarian Cancer
Cervical Cancer
Malignant Lymphoma
Acute Leukemia
Other
The key market players for global Pirarubicin market are listed below:
MicroBiopharm
Lilly
Nanjing Zhengda Tianqing Pharmaceutical
Harbin Yuheng Pharmaceutical
Shandong New Era Pharmaceutical
Zhejiang Haizheng Pharmaceutical
Shenzhen Wanle Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pirarubicin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pirarubicin, with price, sales, revenue and global market share of Pirarubicin from 2019 to 2022.
Chapter 3, the Pirarubicin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pirarubicin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Pirarubicin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pirarubicin.
Chapter 13, 14, and 15, to describe Pirarubicin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Pirarubicin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pirarubicin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 10 Mg Dosage Forms
1.2.3 20 Mg Dosage Forms
1.3 Market Analysis by Application
1.3.1 Overview: Global Pirarubicin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Breast Cancer
1.3.3 Head And Neck Cancer
1.3.4 Bladder Cancer
1.3.5 Ureteral Carcinoma
1.3.6 Carcinoma Of The Renal Pelvis
1.3.7 Ovarian Cancer
1.3.8 Cervical Cancer
1.3.9 Malignant Lymphoma
1.3.10 Acute Leukemia
1.3.11 Other
1.4 Global Pirarubicin Market Size & Forecast
1.4.1 Global Pirarubicin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Pirarubicin Sales in Volume (2017-2028)
1.4.3 Global Pirarubicin Price (2017-2028)
1.5 Global Pirarubicin Production Capacity Analysis
1.5.1 Global Pirarubicin Total Production Capacity (2017-2028)
1.5.2 Global Pirarubicin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pirarubicin Market Drivers
1.6.2 Pirarubicin Market Restraints
1.6.3 Pirarubicin Trends Analysis
2 Manufacturers Profiles
2.1 MicroBiopharm
2.1.1 MicroBiopharm Details
2.1.2 MicroBiopharm Major Business
2.1.3 MicroBiopharm Pirarubicin Product and Services
2.1.4 MicroBiopharm Pirarubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Lilly
2.2.1 Lilly Details
2.2.2 Lilly Major Business
2.2.3 Lilly Pirarubicin Product and Services
2.2.4 Lilly Pirarubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Nanjing Zhengda Tianqing Pharmaceutical
2.3.1 Nanjing Zhengda Tianqing Pharmaceutical Details
2.3.2 Nanjing Zhengda Tianqing Pharmaceutical Major Business
2.3.3 Nanjing Zhengda Tianqing Pharmaceutical Pirarubicin Product and Services
2.3.4 Nanjing Zhengda Tianqing Pharmaceutical Pirarubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Harbin Yuheng Pharmaceutical
2.4.1 Harbin Yuheng Pharmaceutical Details
2.4.2 Harbin Yuheng Pharmaceutical Major Business
2.4.3 Harbin Yuheng Pharmaceutical Pirarubicin Product and Services
2.4.4 Harbin Yuheng Pharmaceutical Pirarubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Shandong New Era Pharmaceutical
2.5.1 Shandong New Era Pharmaceutical Details
2.5.2 Shandong New Era Pharmaceutical Major Business
2.5.3 Shandong New Era Pharmaceutical Pirarubicin Product and Services
2.5.4 Shandong New Era Pharmaceutical Pirarubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Zhejiang Haizheng Pharmaceutical
2.6.1 Zhejiang Haizheng Pharmaceutical Details
2.6.2 Zhejiang Haizheng Pharmaceutical Major Business
2.6.3 Zhejiang Haizheng Pharmaceutical Pirarubicin Product and Services
2.6.4 Zhejiang Haizheng Pharmaceutical Pirarubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Shenzhen Wanle Pharmaceutical
2.7.1 Shenzhen Wanle Pharmaceutical Details
2.7.2 Shenzhen Wanle Pharmaceutical Major Business
2.7.3 Shenzhen Wanle Pharmaceutical Pirarubicin Product and Services
2.7.4 Shenzhen Wanle Pharmaceutical Pirarubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Pirarubicin Breakdown Data by Manufacturer
3.1 Global Pirarubicin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Pirarubicin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Pirarubicin
3.4 Market Concentration Rate
3.4.1 Top 3 Pirarubicin Manufacturer Market Share in 2021
3.4.2 Top 6 Pirarubicin Manufacturer Market Share in 2021
3.5 Global Pirarubicin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Pirarubicin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pirarubicin Market Size by Region
4.1.1 Global Pirarubicin Sales in Volume by Region (2017-2028)
4.1.2 Global Pirarubicin Revenue by Region (2017-2028)
4.2 North America Pirarubicin Revenue (2017-2028)
4.3 Europe Pirarubicin Revenue (2017-2028)
4.4 Asia-Pacific Pirarubicin Revenue (2017-2028)
4.5 South America Pirarubicin Revenue (2017-2028)
4.6 Middle East and Africa Pirarubicin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Pirarubicin Sales in Volume by Type (2017-2028)
5.2 Global Pirarubicin Revenue by Type (2017-2028)
5.3 Global Pirarubicin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Pirarubicin Sales in Volume by Application (2017-2028)
6.2 Global Pirarubicin Revenue by Application (2017-2028)
6.3 Global Pirarubicin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Pirarubicin Sales by Type (2017-2028)
7.2 North America Pirarubicin Sales by Application (2017-2028)
7.3 North America Pirarubicin Market Size by Country
7.3.1 North America Pirarubicin Sales in Volume by Country (2017-2028)
7.3.2 North America Pirarubicin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Pirarubicin Sales by Type (2017-2028)
8.2 Europe Pirarubicin Sales by Application (2017-2028)
8.3 Europe Pirarubicin Market Size by Country
8.3.1 Europe Pirarubicin Sales in Volume by Country (2017-2028)
8.3.2 Europe Pirarubicin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Pirarubicin Sales by Type (2017-2028)
9.2 Asia-Pacific Pirarubicin Sales by Application (2017-2028)
9.3 Asia-Pacific Pirarubicin Market Size by Region
9.3.1 Asia-Pacific Pirarubicin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Pirarubicin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Pirarubicin Sales by Type (2017-2028)
10.2 South America Pirarubicin Sales by Application (2017-2028)
10.3 South America Pirarubicin Market Size by Country
10.3.1 South America Pirarubicin Sales in Volume by Country (2017-2028)
10.3.2 South America Pirarubicin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pirarubicin Sales by Type (2017-2028)
11.2 Middle East & Africa Pirarubicin Sales by Application (2017-2028)
11.3 Middle East & Africa Pirarubicin Market Size by Country
11.3.1 Middle East & Africa Pirarubicin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Pirarubicin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Pirarubicin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Pirarubicin
12.3 Pirarubicin Production Process
12.4 Pirarubicin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Pirarubicin Typical Distributors
13.3 Pirarubicin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---